Combined treatment of sildenafil and inhaled iloprost in pediatric patients with severe pulmonary arterial hypertension

被引：2
|
作者：
Efren Santos-Martinez, Luis [1 ]
Jimenez-Santos, Moises [2 ]
Guillermo Arenas-Fonseca, Jorge [3 ]
Moreno-Gonzalez, Agustina [3 ]
Elena Medina-Concebida, Luz [4 ]
机构：
[1] IMSS, UMAE Hosp Cardiol, Ctr Med Nacl Siglo 21, Dept Hipertens Pulmonar & Func Ventricular Derech, Mexico City, DF, Mexico
[2] IMSS, UMAE Hosp Cardiol, Ctr Med Nacl Siglo 21, Dept Radiol & Imagen, Mexico City, DF, Mexico
[3] IMSS, UMAE Hosp Cardiol, Ctr Med Nacl Siglo 21, Dept Gabinetes, Mexico City, DF, Mexico
[4] IMSS, UMAE Hosp Cardiol, Ctr Med Nacl Siglo 21, Dept Cardiopediat, Mexico City, DF, Mexico
来源：
ARCHIVOS DE CARDIOLOGIA DE MEXICO | 2015年 / 85卷 / 01期
关键词：
D O I：
10.1016/j.acmx.2014.11.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：80 / 84
页数：5
相关论文
共 50 条
  • [21] Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: an observational study
    Gall, Henning
    Sommer, Natascha
    Milger, Katrin
    Richter, Manuel J.
    Voswinckel, Robert
    Bandorski, Dirk
    Seeger, Werner
    Grimminger, Friedrich
    Ghofrani, Hossein-Ardeschir
    BMC PULMONARY MEDICINE, 2016, 16
  • [22] Sildenafil for the Treatment of Pulmonary Hypertension in Pediatric Patients
    Alice J. Huddleston
    Chad A. Knoderer
    Jennifer L. Morris
    Eric S. Ebenroth
    Pediatric Cardiology, 2009, 30 : 871 - 882
  • [23] Sildenafil for the Treatment of Pulmonary Hypertension in Pediatric Patients
    Huddleston, Alice J.
    Knoderer, Chad A.
    Morris, Jennifer L.
    Ebenroth, Eric S.
    PEDIATRIC CARDIOLOGY, 2009, 30 (07) : 871 - 882
  • [24] Acute effects of inhaled iloprost on intracardiac conduction in patients with pulmonary arterial hypertension
    Yildiz, Mustafa
    Kahraman, Serkan
    Surgit, Ozgur
    Agus, Hicaz Zencirkiran
    Uygur, Begum
    Demir, Ali R.
    Kalkan, Mehmet E.
    Sancar, Kadriye Memic
    Oner, Ender
    Gurbak, Ismail
    Kalkan, Ali K.
    HERZ, 2022, 47 (02) : 158 - 165
  • [25] Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial
    Richter, Manuel J.
    Stollfuss, Barbara
    Roitenberg, Alexander
    Kleinjung, Frank
    Graeff, Valentin
    Berghaus, Sabine
    Mueller, Christian
    Ghofrani, Hossein-Ardeschir
    PULMONARY CIRCULATION, 2018, 8 (04)
  • [26] Inhaled iloprost to treat severe pulmonary hypertension -: An uncontrolled trial
    Olschewski, H
    Ghofrani, HA
    Schmehl, T
    Winkler, J
    Wilkens, H
    Höper, MM
    Behr, J
    Kleber, FX
    Seeger, W
    ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) : 435 - +
  • [27] Inhaled iloprost in pulmonary hypertension and severe respiratory failure in childhood
    Ehlen, M
    Esser, R
    Kipping, T
    MONATSSCHRIFT KINDERHEILKUNDE, 2003, 151 (05) : 539 - 543
  • [28] Sustained success of therapy with inhaled iloprost for severe pulmonary arterial hypertension associated with systemic sclerosis and pulmonary fibrosis
    Ahmadi-Simab, K.
    Koehler, A.
    Gross, W. L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (05) : 760 - 762
  • [29] Continuous intravenous iloprost to revert treatment failure of first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension
    Ewert, R.
    Opitz, C. F.
    Wensel, R.
    Winkler, J.
    Halank, M.
    Felix, S. B.
    CLINICAL RESEARCH IN CARDIOLOGY, 2007, 96 (04) : 211 - 217
  • [30] Transitioning from IV/SQ prostanoids to inhaled iloprost in patients with pulmonary arterial hypertension
    Saggar, Rajeev
    Sulica, Roxana
    Williamson, Timothy
    Kim, Nick H.
    Channick, Richard N.
    CHEST, 2006, 130 (04) : 257S - 258S
12345